5th Data Monitoring Committees

Now in its fifth year, ExL Pharma’s Data Monitoring Committees/DSMBs Conference continues to attract the industry’s leading Clinicians and Biostatisticians to discuss strategies for ensuring trial safety and efficacy through independent evaluation of interim clinical data. DMCs offer an opportunity for a team of experts, independent from the trial sponsor, to examine the interim clinical data and make unbiased recommendations for the continuation, alteration and termination of the trial. Incorporating DMCs into trial design and conduct adds additional protection against proceeding with an unsafe product or futile trial design which mitigates risk to subjects, optimizes resource utilization for the sponsor by reassuring study integrity and protects the public from access to unsafe products.

"ExL’s DMC Conference expanded my knowledge of the processes and procedures associated with DMC services and gave me insight into regulatory compliance issues."
- Rhonda Rusinski, RN, BSN, Drug Safety Manager, ICON Clinical Research

Who should Attend

This event is specifically designed for c-levels, department heads, vice presidents, directors and managers at pharmaceutical, biotechnology and medical device companies from the following departments:

  • Statistics/Biostatistics/Biometrics
  • Drug Safety
  • Risk Management/Operations
  • Clinical
  • Development/Operations/Trials/Science/R&D
  • Pharmacovigilance
  • Bioethics
  • Regulatory Affairs
  • Medical Affairs
  • Decision Analysis/Decision Sciences
  • Clinical Operations
  • Strategic Operations/Planning
  • Epidemiology

This conference is also of interest to:

  • Statistical Analysis Companies
  • Data Management Services
  • Contract Research Organizations
  • IRBs